|
LOC220930 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.086000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.468190E-01 |
| Normal-vs-Stage2 |
7.826800E-01 |
| Normal-vs-Stage3 |
4.765600E-04 |
| Normal-vs-Stage4 |
6.019100E-03 |
| Stage1-vs-Stage2 |
3.637600E-01 |
| Stage1-vs-Stage3 |
1.551900E-04 |
| Stage1-vs-Stage4 |
2.399900E-02 |
| Stage2-vs-Stage3 |
5.861000E-03 |
| Stage2-vs-Stage4 |
3.578400E-02 |
| Stage3-vs-Stage4 |
2.932200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.089950E-02 |
| Normal-vs-AfricanAmerican |
3.861800E-01 |
| Normal-vs-Asian |
7.848600E-01 |
| Caucasian-vs-AfricanAmerican |
2.01749999999556E-05 |
| Caucasian-vs-Asian |
1.198380E-01 |
| AfricanAmerican-vs-Asian |
9.005000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.815740E-02 |
| Normal-vs-Female |
1.096840E-01 |
| Male-vs-Female |
2.046200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.438400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.230810E-01 |
| Normal-vs-Age(61-80Yrs) |
1.092300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.532000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.280000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.699600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.312000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.182200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.482600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.973000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.935000E-01 |
| Normal-vs-Grade 2 |
3.922600E-01 |
| Normal-vs-Grade 3 |
6.461700E-03 |
| Normal-vs-Grade 4 |
2.33499999999776E-05 |
| Grade 1-vs-Grade 2 |
2.100800E-01 |
| Grade 1-vs-Grade 3 |
3.385000E-03 |
| Grade 1-vs-Grade 4 |
1.79434999999506E-05 |
| Grade 2-vs-Grade 3 |
7.618700E-04 |
| Grade 2-vs-Grade 4 |
4.04519999719355E-08 |
| Grade 3-vs-Grade 4 |
5.761100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.737600E-01 |
| Normal-vs-ccB subtype |
1.599250E-04 |
| ccA subtype-vs-ccB subtype |
1.38629999701934E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.689900E-02 |
| Normal-vs-N1 |
4.354000E-02 |
| N0-vs-N1 |
1.957030E-01 |
|
|
